Orthofix Medical (OFIX) Change in Accured Expenses (2010 - 2026)

Orthofix Medical has disclosed Change in Accured Expenses across 16 years of filings, most recently posting -$5.2 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 75.59% year-over-year to -$5.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (up 363.51% YoY) and the FY2025 annual result came in at -$2.3 million, down 123.81% from the prior year.
• Change in Accured Expenses fell to -$5.2 million in Q1 2026, from $6.8 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $12.7 million in Q3 2025 and troughed at -$21.4 million in Q1 2025.
• A 5-year average of $396117.6 and a median of $2.9 million in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 161.67% — and 2024, when it soared 936.88%.
• Tracing OFIX's Change in Accured Expenses over 5 years: stood at $5.2 million in 2022, then dropped by 21.34% to $4.1 million in 2023, then surged by 203.18% to $12.4 million in 2024, then tumbled by 45.28% to $6.8 million in 2025, then slumped by 176.96% to -$5.2 million in 2026.
• Business Quant data shows OFIX's Change in Accured Expenses at -$5.2 million in Q1 2026, $6.8 million in Q4 2025, and $12.7 million in Q3 2025.